Great Hill Capital LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 7,350 shares of the company’s stock, valued at approximately $688,000. Direxion Daily S&P Biotech Bull 3x Shares comprises about 0.1% of Great Hill Capital LLC’s holdings, making the stock its 28th biggest position. Great Hill Capital LLC owned about 0.11% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $3,208,000. IMC Chicago LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth $3,806,000. McGuire Investment Group LLC grew its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 30.2% in the third quarter. McGuire Investment Group LLC now owns 6,547 shares of the company’s stock worth $613,000 after purchasing an additional 1,519 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 68.7% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 506 shares of the company’s stock worth $47,000 after purchasing an additional 206 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares during the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
Direxion Daily S&P Biotech Bull 3x Shares stock opened at $176.87 on Thursday. Direxion Daily S&P Biotech Bull 3x Shares has a 1-year low of $32.55 and a 1-year high of $198.18. The business has a fifty day moving average price of $168.24 and a 200-day moving average price of $130.71.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Read this or regret it forever
- Unlocked: Elon Musk’s Next Big IPO
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
